A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer
IntroductionClinical workflows to analyze variants of unknown significance (VUSs) found in clinical next generation sequencing (NGS) are labor intensive, requiring manual analysis of published data for each variant. There is a strong need for tools and resources that provide a consistent way to anal...
Saved in:
Main Authors: | Amith Rangarajan, Ilona Sviezhentseva, Emma Gunderson, Yana Pikman, Matthew P. Jacobson, Beth Apsel Winger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1599389/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel kinase-activating genetic events in non-small cell lung carcinomas
by: Elena V. Preobrazhenskaya, et al.
Published: (2025-07-01) -
HLA diversity in the Russian population assessed by next generation sequencing
by: E. G. Khamaganova, et al.
Published: (2021-06-01) -
The NeXT book /
by: Webster, Bruce F.
Published: (1989) -
NEXT-GENERATION GENE SEQUENCING AND ITS APPLICATIONS IN ONCOHEMATOLOGY
by: I. M. Barkhatov, et al.
Published: (2017-01-01) -
An innovative full-size pathogenic tandem duplication mutation precise detection system based on next-generation sequencing
by: Li-Li Zhang, et al.
Published: (2025-07-01)